RxDoctor Payments Data

Jeniffer Alberry

Family · Alexandria Bay, NYNPI 1407898356

Payments from drug & device makers

$1,485in general payments, 2019–2025

Across 73 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$255
  • Novo Nordisk$242
  • Lilly USA, LLC$177
  • Amgen$152
  • AbbVie$135
  • AstraZeneca$104
  • plus $420 from 13 others

What the payments were for

  • Food & beverage$1,485100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,485 in reported general payments places this provider in the 75th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$28,837
Medicare patients
143
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$77,599
FarxigaDapagliflozin Propanediol42$51,689
EliquisApixaban44$41,601
XareltoRivaroxaban22$35,090
TrulicityDulaglutide16$30,738
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$30,040
JardianceEmpagliflozin17$21,074
SymbicortBudesonide/Formoterol Fumarate37$13,422
Breo ElliptaFluticasone/Vilanterol13$8,140
PremarinEstrogens, Conjugated16$6,793
Fluoxetine Hcl21$3,916
Adderall XrDextroamphetamine/Amphetamine12$2,342
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$2,298
Atorvastatin Calcium210$2,290
Albuterol Sulfate HfaAlbuterol Sulfate51$2,225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$242$77,59947 claims
AstraZenecaFarxiga, Symbicort$104$65,11079 claims
PfizerEliquis, Premarin$16$48,39460 claims
GSKTrelegy Ellipta, Breo Ellipta$255$38,18035 claims
Johnson & JohnsonXarelto$40$35,09022 claims
Lilly USA, LLCTrulicity$177$30,73816 claims
AbbVieSynthroid$135$97619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,883 family providers in New York.

Other family in Alexandria Bay

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →